Return to: Previous Page

Pharmacy-benefit manager stocks pressured as White House calls for lower biotech prices2-9-18 3:51 PM EST

Shares of pharmacy-benefit managers fell Friday after the White House released a paper pushing for lower biotech drug prices. Shares of Express Scripts Holding Co. (ESRX) declined 2.8%, CVS Health Corp. (CVS) shares slipped 1.5%, while shares of UnitedHealth Group Inc. (UNH), with its OptumRx PBM business, swung from a slight loss to be up 0.5%. On Friday, the White House's Coucil of Economic Advisers released a white paper entitled "Reforming Biopharmaceutical Pricing at Home and Abroad" ( which called for reducing prices of biotech drugs while raising incentives for medical innovation to promote competition.

-Wallace Witkowski; 415-439-6400;


(END) Dow Jones Newswires

02-09-18 1551ET

Copyright (c) 2018 Dow Jones & Company, Inc. Return to: Previous Page